• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.57% Nasdaq Down 0.75%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.35 Down 0.07(4.93%) 2:31PM EDT - Nasdaq Real Time Price
    Prev Close:1.42
    Open:1.38
    Bid:1.35 x 2500
    Ask:1.36 x 8100
    1y Target Est:1.83
    Beta:-0.067087
    Earnings Date:May 10 - May 16 (Est.)
    Day's Range:1.35 - 1.45
    52wk Range:0.75 - 2.50
    Volume:433,392
    Avg Vol (3m):427,916
    Market Cap:209.64M
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 4.93%209.64M
    LLYDown 1.76%79.64B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.08
    Quarterly EPS Est (Mar-16) :-0.03
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback